Description
A total of 1,396 EFIGA cohort samples were sequenced at NYGC and USUHS using the Illumina HiSeqX platform. The BAM files were sent to GCAD for processing through the VCPA1.1 pipeline. A total of 1,373 samples passed sequencing metrics and quality control checks.
Sex
Total number of samples: 1,603
Female 1,012 63.1 %
Male 591 36.9 %
Race
Total number of samples: 1,602
American Indian/Alaska Native | 1 |
Native Hawaiian or Other Pacific Islander | 3 |
Black or African American | 229 |
White | 311 |
Other | 1,040 |
NA | 18 |
Ethnicity
Total number of samples: 1,604
Not Hispanic or Latino
187
11.7%
Hispanic or Latino
1,413
88.1%
Not Applicable/Not Available
4
0.2%
Diagnosis
Total number of samples: 1,675
AD | ||
---|---|---|
Control | 856 | 51.1% |
Case | 539 | 32.2% |
1 | 0.1% | |
Other | 208 | 12.4% |
Unknown | 34 | 2.0% |
37 | 2.2% |
APOE
Total number of samples: 1,603
- 2217 (1.1%)
- 23120 (7.5%)
- 2473 (4.6%)
- 33587 (36.6%)
- 34600 (37.4%)
- 44206 (12.9%)